Heart (Hypertrophy)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Hypertrophy).php on line 2
Heart (Hypertrophy)

LE WE PMID CA

Heart (Hypertrophy)

7852

Herz (Hypertrophie)

Calcineurin

Calmodulin dependent protein kinase

Cell volume

Ciclosporin ttMPT

ERS UFR (Diseases)

FGF2

Heart (Electrocardiography)

Heart (Hypertrophy)

Histone deacetylase

Ion channel (Anion)

Ion channel (VRAC volume regulated anion channel)

Leptin

MEF2c

Thyroxine

2009 1	AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. [19228820] Circulation 119(10): e251-61 (2009)
2010 2	The role of microRNA-133 in cardiac hypertrophy uncovered. [20056941] Circ Res 106(1): 16-8 (2010)
2011 3	Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy. [21151616] J Biomed Biotechnol 2011(-): 928326 (2011)
2004 4	Network integration of the adrenergic system in cardiac hypertrophy. [15276464] Cardiovasc Res 63(3): 391-402 (2004)
2004 5	Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. [15276465] Cardiovasc Res 63(3): 403-13 (2004)
2004 6	Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. [15276470] Cardiovasc Res 63(3): 450-7 (2004)
2004 7	Fibroblast growth factor 2 isoforms and cardiac hypertrophy. [15276471] Cardiovasc Res 63(3): 458-66 (2004)
2004 8	Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. [15276472] Cardiovasc Res 63(3): 467-75 (2004)
2004 9	Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. [15276473] Cardiovasc Res 63(3): 476-86 (2004)
2004 10	Myocyte hypertrophy and apoptosis: a balancing act. [15276474] Cardiovasc Res 63(3): 487-99 (2004)
2004 11	Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. [15276462] Cardiovasc Res 63(3): 373-80 (2004)
2008 12	Leptin-induced cardiac hypertrophy: RhoAing a lipid raft down a protective p38 MAPK signalling stream? [18006446] Cardiovasc Res 77(1): 4-5 (2008)
2005 13	Genetics of left ventricular hypertrophy and its regression. [15773670] Rev Port Cardiol 24(1): 105-17 (2005)
2002 14	Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy. [12008744] Endocr J 49(1): 1-13 (2002)
2011 15	New molecular mechanisms for cardiovascular disease: cardiac hypertrophy and cell-volume regulation. [21757844] J Pharmacol Sci 116(4): 343-9 (2011)
2007 16	Re-employment of developmental transcription factors in adult heart disease. [17161634] Semin Cell Dev Biol 18(1): 117-31 (2007)
2008 17	Factors and mechanisms involved in left ventricular hypertrophy and the anti-hypertrophic role of nitric oxide. [18592095] Arq Bras Cardiol 90(6): 409-16 (2008)
2010 18	New insights into the molecular phenotype of eccentric hypertrophy. [20381498] J Mol Cell Cardiol 49(2): 153-6 (2010)
2010 19	The calcineurin-myocyte enhancer factor 2c pathway mediates cardiac hypertrophy induced by endoplasmic reticulum stress in neonatal rat cardiomyocytes. [20207814] Am J Physiol Heart Circ Physiol 298(5): H1499-509 (2010)
2010 20	Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy. [20005976] Vascul Pharmacol 52(3-4): 113-9 (2010)
PMC 21	Transcriptional regulation patterns revealed by high resolution chromatin immunoprecipitation during cardiac hypertrophy. [23229551] J Biol Chem 288(4):2546-58 (2013)
PMC 22	Signaling effectors underlying pathologic growth and remodeling of the heart. [23281408] J Clin Invest 123(1):37-45 (2013)
PMC 23	Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. [23842089] Proc Natl Acad Sci U S A 110(31):12661-6 (2013)
PMC 24	C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle. [22828478] J Mol Cell Cardiol 55():156-64 (2013)
PMC 25	Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy. [23381122] Basic Res Cardiol 108(2):335 (2013)
PMC 26	Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy. [23176298] Br J Pharmacol 168(8):1794-807 (2013)
PMC 27	A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. [23447532] J Biol Chem 288(16):11216-32 (2013)
PMC 28	Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy. [24101493] Proc Natl Acad Sci U S A 110(43):E4079-87 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Hypertrophy).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heart (Hypertrophy).php on line 92